Mehran Nowfar-Rad, MD
Dermatopathology · Porter Ranch, CANPI 1912979048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $832 and has fallen 83.1% since, to $141 in 2025.
Across 61 payments — averaging $26.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$314
- Amgen$274
- Lilly USA, LLC$236
- AbbVie$162
- Dermavant Sciences, Inc.$79
- Pfizer$79
- plus $484 from 15 others
What the payments were for
- Food & beverage$1,629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $314 |
| Amgen | 10 | $274 |
| Lilly USA, LLC | 13 | $236 |
| AbbVie | 3 | $162 |
| Dermavant Sciences, Inc. | 4 | $79 |
| Pfizer | 4 | $79 |
| Johnson & Johnson | 3 | $77 |
| UCB, Inc. | 3 | $75 |
| Radius Health, Inc. | 2 | $41 |
| Sun Pharmaceutical Industries Inc. | 2 | $40 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $36 |
| Coloplast | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Dynavax Technologies Corporation | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Bristol Myers Squibb | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,629 in reported general payments places this provider in the 70th percentile of 76 dermatopathology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 61 | $1,555 |
| Clobetasol Propionate | 29 | $646 |
| Ketoconazole | 53 | $628 |
| Metronidazole | 13 | $398 |
| Clindamycin Phosphate | 25 | $351 |
| Mupirocin | 37 | $291 |
| Doxycycline Hyclate | 22 | $255 |
| Hydroxyzine Hcl | 19 | $130 |
| Triamcinolone Acetonide | 16 | $45 |
| Hydrocortisone | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Porter Ranch
- Christiane QuerfeldDuarte$107K
- Brittney de ClerckLos Angeles$56K
- Brook Brouhala Jolla$20K
- Vishwas ParekhDuarte$13K
- Susan Detwilerla Jolla$7K
- Mandy Ramanila Canada$7K
- Curt VogelEncinitas$7K
- Karen Sherwoodla Canada$6K
- John Honchla Canada$6K
- Stacy WhitelockFullerton$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.